Source link : https://www.newshealth.biz/health-news/gene-silencing-benefit-of-zodasiran-in-hyperlipidemia/
LYON, France — The drug zodasiran (formerly ARO-ANG3), which targets the production of a liver protein, substantially lowers triglyceride and a range of lipoprotein levels in patients with mixed hyperlipidemia who are stable on optimal statin therapy, according to ARCHES-2 study investigators. The hepatocyte-targeted small interfering (si) RNA was designed to silence the expression of […]
Author : News Health
Publish date : 2024-06-28 21:21:48
Copyright for syndicated content belongs to the linked Source.
Categories